Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Avacta Group announced the appointment of Neil Bell as Chief Development Officer of Avacta Life Sciences with immediate effect.
read more
Wednesday, September 02, 2020
Avacta Group has entered into an agreement with Abingdon Health for the manufacture of Avacta’s saliva-based rapid SARS-CoV-2 antigen test as part of its ongoing expansion of manufacturing capacity.
read more
Avacta has entered into a collaboration with Adeptrix to develop a high throughput COVID-19 antigen test using Adeptrix’s proprietary BAMS™ platform.
read more
Avacta Group announced collaborative work with the Centre for Virus Research at the University of Glasgow has shown that Affimer reagents which bind to the SARS-COV-2 virus spike protein prevent infection of human cells by a SARS-COV-2 model virus.
read more
Avacta has begun work with the UK government’s CONDOR program to evaluate and clinically validate the high throughput COVID-19 bead-assisted mass spectrometry laboratory assay.
read more
Avacta has announce the first Affimer-based rapid test strips to detect SARS-COV-2 spike protein have been developed and evaluated by Avacta’s partners at Cytiva and show positive initial performance data.
read more
Group announced it is shipping Affimer reagents for COVID-19 antigen testing to its diagnostic test development partners.
read more
Avacta Group has entered into a license agreement with Biokit to incorporate Affimer reagents into a Biokit IVD product.
read more
Tuesday, December 22, 2020
Avacta Group has entered into a license agreement with Astrea Bioseparations for the use of the Affimer platform in affinity purification applications.
read more
Tuesday, September 08, 2020
Avacta has announced it will launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global research efforts into the coronavirus that causes COVID-19.
read more
Avacta Group has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences.
read more
Avacta announced an expansion of its collaboration and license agreement with Daewoong and AffyXell Therapeutics.
read more
Avacta has entered into a collaboration with Integumen to evaluate recently generated Affimer reagents that bind the SARS-COV-2 spike protein for the detection of the coronavirus in waste water, to provide a real-time alert system to warn of ...
read more
Monday, December 10, 2018
Avacta Group and LG Chem Life Sciences announced a multi-target collaboration and development agreement.
read more
Avacta has entered into an exclusive distribution agreement with Medusa19 for direct-to-consumer sales of a saliva-based rapid test for the COVID-19 antigen.
read more